Atlas Trials

Assessment of Immunogenicity of Zostavax® in Patients With Antibody Deficiency 60 Years of Age and Older

Clinical trial NCT02960399 · TERMINATED

Trial details

NCT number
NCT02960399
Sponsor
University of South Florida
Status
TERMINATED
Phase
Not Applicable
Study type
INTERVENTIONAL
Common Variable Immune DeficiencySpecific Antibody DeficiencyX-linked Agammaglobulinemia
Start date
2015-12-01
Primary completion
2017-12-01
Enrollment
2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.